Clinical Nutrition — TCA and Drug Interactions

Clinical Nutrition · Clinical Specialties

How it begins

Un análisis clínico avanzado sobre la fisiopatología, diagnóstico e intervenciones en Trastornos de la Conducta Alimentaria (TCA), la dinámica metabólica del Síndrome de Realimentación y las interacciones farmacocinéticas y farmacodinámicas críticas entre nutrientes y agentes terapéuticos.

What it covers

1. Neurobiology of Food Regulation
2. · The Homeostatic Pathway: The Arcuate Nucleus (ARC)
3. · Peripheral Signals and the Entero-Cerebral Axis
4. · The Hedonic Pathway and its Dysfunction in EDs
5. Classification and Diagnostic Criteria of EDs
6. · 1. Anorexia Nervosa (AN)
7. · 2. Bulimia Nervosa (BN)
8. · 3. Binge Eating Disorder
9. · 4. Avoidant/Restrictive Food Intake Disorder (ARFID/TARA)
10. Systemic Pathophysiology and Organic Complications
11. · 1. Cardiovascular Complications
12. · 2. Endocrine and Hypothalamic-Pituitary Complications
13. · 3. Gastrointestinal disorders
14. · 4. Electrolyte Alterations and Kidney Function
15. · 5. Hematological and Immunological Complications
16. Advanced Nutritional Evaluation
17. · Establishing Target Weight and Body Composition
18. · Useful Analytical Biomarkers in Monitoring
19. · Assessment of the Basal Metabolic Rate
20. Refeeding Syndrome (RS)
21. · Pathophysiology: The Transition from Catabolism to Anabolism
22. · Clinical Manifestations of Electrolyte Deficiency
23. · Risk Stratification (NICE Criteria)
24. · Clinical Protocol for the Prevention and Management of SR
25. Integrated Nutritional-Pharmacological Treatment
26. · Nutritional Rehabilitation: Macronutrient Progression
27. · Evidence-Based Pharmacotherapy
28. Fundamentals of Drug-Nutrient Interactions
29. Interactions in the Gastrointestinal Tract
30. · Absorption Modulation: Physiological Mechanisms
31. · Chelation Phenomenon and Direct Chemical Incompatibility
32. Modulation of Drug Metabolism by Food
33. · 1. Enzyme Inhibition: The Effect of Grapefruit Juice
34. · 2. Enzyme Induction: Grilled and Cruciferous Foods
35. · 3. Modulation of Transporters: P-Glycoprotein (P-gp)
36. Drugs That Alter Nutritional Status
37. · 1. Drugs That Induce Nutrient Malabsorption
38. · 2. Drug-Induced Modulation of Body Weight
39. Interactions in Pharmacopsychiatry Applied to EDs
40. · 1. Monoamine Oxidase Inhibitors (MAOI) and Tyramine: "The Cheese Effect"
41. · 2. Lithium Carbonate, Sodium and Hydration
42. Interactions in Enteral and Parenteral Nutritional Support
43. · 1. Enteral Nutrition and Medications: Physical-Chemical Incompatibilities
44. · 2. Parenteral Nutrition: The Danger of Precipitated Calcium and Phosphorus
45. · 3. Destabilization of Lipid Emulsions in Parenteral
46. Monitoring Protocol and Alarm Signals
47. · Intervention Algorithm and Analytical Monitoring Frequency
48. · Expert Level Critical Alarm Thresholds
49. Clinical Cases and Advanced Medical Correlations
50. · Clinical Case 1: Management of Extreme Anorexia Nervosa, Refeeding Syndrome and QTc Prolongation
51. · Clinical Case 2: Critical Drug-Nutrient Interaction due to MAOI and Enteral Nutrition Obstruction